A cancer vaccine developer has appointed a life sciences entrepreneur as chairman. Dr. Wolfgang Oster is a managing partner for the life sciences fund at PolyTechnos, which focuses on investment in early stage, technology-oriented companies. Although the venture capital firm’s focus has been primarily on German companies, it has invested in several U.S.-based life sciences […]
The former chairman of BNP Sunstone and a pharmaceutical veteran has joined the board of a firm developing a cancer vaccine. Martyn Greenacre has served as a CEO of Delsys Pharmaceutical Corp., a formulation and drug-delivery system company later acquired by Elan. He worked in the European division of SmithKline Beecham in several roles that […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Formula Pharmaceuticals is raising $13 million in a series B financing round for a vaccine to be used during first remission for acute myeloid leukemia and other aggressive cancers. The investment will be used to support the two Phase II clinical trials of the multi-peptide immunotherapeutic at Memorial Sloane-Kettering Cancer Center that will take two years. Although […]